cell manufacturing
cell manufacturing
Novo Nordisk’s $41B Plant Expansion Creates 1000 Jobs and Meets Growing Demand
🏭 Novo Nordisk is building a $4.1B plant in Clayton, NC, creating 1,000 jobs and expanding manufacturing space. 💉💼
Revolutionary Partnership Turbocharges Biopharma Drug Development
🔍 Abzena and Argonaut partner to offer drug development and manufacturing support for biopharma companies. 💊🤝🚀💪👥
Unlocking Advanced Therapy’s Potential with AI: The Key Ingredients
🌍 Advanced therapy manufacturers must have robust hardware and monitoring software in place before benefiting from AI. 🤖📈
Revolutionary Approach to Manufacturing Macrophages
🧪💡✨ Meeting the Challenge of Manufacturing Macrophages explores how Resolution Therapeutics overcomes obstacles to produce effective macrophage therapy.
WuXi Biologics Supercharges Manufacturing with 5000L Bioreactors!
⚡ WuXi Biologics upgrades manufacturing capability with installation of three 5,000L single-use bioreactors! 🏭✨🔝
Revolutionary Genomic Tech Promises Cheaper Animal Vaccines
📅 June 3, 2024: High costs and technical difficulties limit animal vaccine development. 💉 New QTL technology offers affordable and effective vaccines. 🔬🚀
Revolutionary Cell Therapy Platform: Faster Cheaper and Automated!
🚀 Cytiva launches Sefia platform, speeding up cell-based treatments production. 💉 Sefia lowers costs, reduces errors, and saves time. 🔬 Scalable and flexible for all manufacturing stages. 💼 Direct marketing to customers.
Game-Changing Partnership: AGC Biologics and BioConnection Revolutionize Biodrug Development and Manufacturing
📢 AGC Biologics and BioConnection partner to offer end-to-end biopharmaceutical development and manufacturing services. 👥💊🌍⚠️🔒💡
Revolutionizing Cell Therapy Manufacturing: Cheaper and Accessible
📰 Getting the Economical Edge on Cheaper Cell Therapy Manufacturing explores Alder Therapeutics' cost-effective approach to therapy development. 💰🔬🧪🔬🔬🌱
Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases
🙌 Multiply Labs and Retro Biosciences partner to automate cell therapy manufacturing for age-related diseases, valued at $85 million. 🌍
